“…Any evaluation of the merits of a production strategy must include both evaluation of the available accelerator technology, and the subsequent techniques for efficient and high purity 99m Tc extraction and conversion to labeled compounds of medical utility. Photonuclear production has been demonstrated as a viable option, with source photons from Bremsstrahlung (Avagyan 2014, Bennett 1999, Dzhilavyan 2011, Dovbnya 2011, Sabel'nikov 2006, Starovoitova 2014 or Compton sources (Habs 2011). This method would provide a source of 99m Tc (half life 6 hours, the primary decay product from 99 Mo) without the security concerns surrounding high enrichment uranium (HEU) targets, or the need for dedicated nuclear reactor facilities.…”